Humacyte (HUMA) Cash from Investing Activities Growth (1y) (2021 - 2026)
Humacyte (HUMA) Cash from Investing Activities Growth (1y) (2021 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Cash from Investing Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
723,416.35 Bn |
723,416.32 Bn |
- |
- |
| 2 |
Belite Bio |
57,340.00 Bn |
57,340.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
19,125.08 Bn |
19,125.08 Bn |
- |
-114.28% |
| 4 |
Legend Biotech |
3,262.00 Bn |
3,261.71 Bn |
242.10 Mn |
826.39% |
| 5 |
Akari Therapeutics |
1,789.67 Bn |
1,789.67 Bn |
- |
- |
| 6 |
Evaxion A |
1,480.39 Bn |
1,480.37 Bn |
- |
- |
| 7 |
Psyence Biomedical |
241.78 Bn |
241.78 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
113.54 Bn |
106.29 Bn |
2.59 Bn |
-674.01% |
| 9 |
Abivax |
94.26 Bn |
94.26 Bn |
- |
- |
| 10 |
Humacyte |
267.09 Mn |
218.55 Mn |
-1.54 Mn |
23.25% |
| Date | Value |
|---|
| Mar 31, 2026 |
23.25% |
| Dec 31, 2025 |
38.10% |
| Sep 30, 2025 |
94.75% |
| Jun 30, 2025 |
-208.70% |
| Mar 31, 2025 |
41.69% |
| Dec 31, 2024 |
58.00% |
| Sep 30, 2024 |
-89.45% |
| Jun 30, 2024 |
-111.34% |
| Mar 31, 2024 |
66.06% |
| Dec 31, 2023 |
-102.88% |
| Sep 30, 2023 |
-133.65% |
| Jun 30, 2023 |
1,310.45% |
| Mar 31, 2023 |
-5,136.36% |
| Dec 31, 2022 |
164.79% |
| Sep 30, 2022 |
-154.22% |
| Jun 30, 2022 |
-112.70% |
| Mar 31, 2022 |
24.14% |
| Dec 31, 2021 |
91.96% |
| Sep 30, 2021 |
99.92% |
